- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prosthetic Treatment in South Africa
Total 573 results
-
Watson PharmaceuticalsCompletedBenign Prostatic HyperplasiaUnited States
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Sunnybrook Health Sciences CentreExact ImagingRecruitingProstate CancerUnited States, Canada, Austria, France, Germany, Spain, Belgium
-
Aragon Pharmaceuticals, Inc.Active, not recruiting
-
VA Office of Research and DevelopmentRecruitingMetastatic Prostate CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | PSA Failure | PSA Progression | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Psychosocial Effects of Cancer and Its TreatmentUnited States, Canada
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
GP-PharmCompletedProstate CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, United Kingdom
-
Axsome Therapeutics, Inc.CompletedTreatment Resistant Major Depressive DisorderUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
AstraZenecaRecruitingProstate CancerUnited States, Spain, United Kingdom, Netherlands, Canada, Australia
-
Trans Tasman Radiation Oncology GroupCompletedNasopharyngeal Cancer | Anal Cancer | Intermediate Risk Prostate Cancer | Prostate Cancer (Post Prostatectomy)Australia
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingProstatic Neoplasms, Castration-ResistantBelgium, United States, United Kingdom, Canada, Israel, Spain, Italy
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
Watson PharmaceuticalsCompletedProstatic Hyperplasia | NocturiaUnited States
-
Clarity Pharmaceuticals LtdActive, not recruitingBiochemical Recurrence of Malignant Neoplasm of ProstateUnited States
-
AstraZenecaCompletedProstate CancerSweden, United States, Australia, France, United Kingdom, Poland, Finland, Netherlands, Norway, Belgium, Canada, Indonesia, Denmark, Switzerland
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States, Greece, Switzerland, United Kingdom
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, France, Australia, Canada, Spain, United Kingdom, Italy, Belgium
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
Bristol-Myers SquibbAstellas Pharma Inc; Clovis Oncology, Inc.Active, not recruitingProstate CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Mexico, Spain
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
Propella TherapeuticsRecruitingProstate Cancer | mCRPC | mCSPCUnited States
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
PfizerRecruitingAcute Treatment of MigraineUnited States, Spain, Poland
-
Abbott Medical DevicesActive, not recruitingHeart Failure | Mitral Regurgitation | Mitral Valve Regurgitation | Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure SubjectsUnited States, Canada
-
McMaster UniversityCanadian Cancer Society (CCS); Prostate Cancer CanadaRecruitingCardiovascular Disease | Prostate CancerUnited States, Canada, Australia, Brazil, Israel, Turkey, Colombia
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, France, Mexico, Sweden, Canada, Australia, Italy, Colombia, Denmark, Argentina, Chile, Spain, Germany, Puerto Rico, United Kingdom, Czech Republic, Romania, Norway, Poland, Netherlands, Brazil, Hungary, Turkey, Greece
-
The University of QueenslandQueensland Children's Hospital; Griffith University; Royal Brisbane and Women... and other collaboratorsRecruitingWound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site ReactionsAustralia, France
-
Warner ChilcottCompletedBenign Prostatic HyperplasiaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial Cancer | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Janssen Biotech, Inc.Active, not recruitingProstate Cancer | Prostatic NeoplasmUnited States
-
DendreonTerminatedCastration-Resistant Prostate CancerUnited States
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Eli Lilly and CompanyCompletedProstate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States, Spain, Australia, Denmark, Korea, Republic of, Belgium, Singapore, Finland, Netherlands, France, Austria, Germany, Israel, United Kingdom, Italy, Japan, Lithuania, Poland, Russian Federation, Slovakia, Sweden
-
Laekna LimitedActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Korea, Republic of
-
AstraZenecaBayerRecruitingMetastatic Prostate CancerItaly, United Kingdom, Australia, United States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria